Cortical M1 receptor concentration increases without a concomitant change in function in Alzheimer's disease
- 30 September 2010
- journal article
- Published by Elsevier BV in Journal of Chemical Neuroanatomy
- Vol. 40 (1), 63-70
- https://doi.org/10.1016/j.jchemneu.2010.03.005
Abstract
No abstract availableKeywords
This publication has 73 references indexed in Scilit:
- Neuropathology of nondemented aging: Presumptive evidence for preclinical Alzheimer diseaseNeurobiology of Aging, 2009
- No change in cortical muscarinic M2, M3 receptors or [35S]GTPγS binding in schizophreniaLife Sciences, 2006
- Relationship between Alzheimer’s disease clinical stage and Gq/11 in subcellular fractions of frontal cortexJournal of Neural Transmission, 2004
- Selective cognitive dysfunction in acetylcholine M1 muscarinic receptor mutant miceNature Neuroscience, 2002
- Regulation of phospholipase Cβ activity by muscarinic acetylcholine and 5-HT2 receptors in crude and synaptosomal membranes from human cerebral cortexNeuropharmacology, 2001
- Muscarinic receptor subtype selective toxinsLife Sciences, 1997
- Reliability of the National Institutes of Health Stroke ScaleStroke, 1997
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991
- Physostigmine restores3H-acetylcholine efflux from Alzheimer brain slices to normal levelJournal of Neural Transmission, 1986
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984